Abvc Biopharma Stock Investor Sentiment

ABVC Stock  USD 0.80  0.01  1.23%   
About 63% of ABVC Biopharma's investor base is looking to short. The analysis of the overall investor sentiment regarding ABVC Biopharma suggests that many traders are alarmed. The current market sentiment, together with ABVC Biopharma's historical and current headlines, can help investors time the market. In addition, many technical investors use ABVC Biopharma stock news signals to limit their universe of possible portfolio assets.
  
a day ago at www.macroaxis.com         
Acquisition by Smith J.b. of tradable shares of ABVC Biopharma at 0.05 subject to Rule 16b-3
Macroaxis News
2 days ago at finance.yahoo.com         
ABVC and BioLite Japan Implement Strategy to Advance Japans Biotech Innovation Into Global Markets
Yahoo News
over a week ago at news.google.com         
ABVC BioPharma Announces Potential 7M Cash Licensing Income from Existing Agreements in 2025 - Yahoo...
Google News at Macroaxis
over a week ago at thelincolnianonline.com         
ABVC BioPharma, Inc. Short Interest Down 25.0 percent in January
news
over two weeks ago at finance.yahoo.com         
Positive Market Response in Asia Fuels Potential Revenue Growth for ABVC and BioKey, Marching Into G...
Yahoo News
over a month ago at www.macroaxis.com         
Acquisition by Smith J.b. of tradable shares of ABVC Biopharma at 0.75 subject to Rule 16b-3
Macroaxis News
over a month ago at finance.yahoo.com         
ABVC BioPharma and AiBtl BioPharmas Worldwide Business Development Team Participate in the 43rd Annu...
Yahoo News
over a month ago at finance.yahoo.com         
ABVC BioPharma s ADHD and MDD Drug Polygala Tenuifolia a Natural Wonder With Potential of Transformi...
Yahoo News
over a month ago at finance.yahoo.com         
AiBtl BioPharma Strengthens Partnership With ABVC BioPharma, Paying 150,000 in Licensing Fees
Yahoo News
over a month ago at finance.yahoo.com         
ABVC BioPharma, Inc. Granted Additional 180-Day Grace Period to Regain Compliance With Nasdaq Bid Pr...
Yahoo News
over a month ago at finance.yahoo.com         
Acquisition by Krotine Frank Thomas of 169000 shares of ABVC Biopharma at 0.51 subject to Rule 16b-3
Yahoo News
over a month ago at finance.yahoo.com         
ABVC BioPharma Secures an Additional Patent for ADHD Treatment, in Addition to the Granted U.S. and ...
Yahoo News
over two months ago at gurufocus.com         
ABVC BioPharma Seeks to Revolutionize Mental Health Treatment With a Safe Prozac Alternative, ...
Gurufocus Stories at Macroaxis
over two months ago at finance.yahoo.com         
ABVC BioPharma Secures 200,000 in First Cash Licensing Payment From Oncology Products Partner, Total...
Yahoo News
over two months ago at gurufocus.com         
ABVC BioPharma Secures 200,000 in First Cash Licensing Payment From Oncology Products Partner, ...
Gurufocus Stories at Macroaxis
Far too much social signal, news, headlines, and media speculation about ABVC Biopharma that are available to investors today. That information is available publicly through ABVC media outlets and privately through word of mouth or via ABVC internal channels. However, regardless of the origin, that massive amount of ABVC data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of ABVC Biopharma news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of ABVC Biopharma relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to ABVC Biopharma's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive ABVC Biopharma alpha.

ABVC Biopharma Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for ABVC Stock analysis

When running ABVC Biopharma's price analysis, check to measure ABVC Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ABVC Biopharma is operating at the current time. Most of ABVC Biopharma's value examination focuses on studying past and present price action to predict the probability of ABVC Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ABVC Biopharma's price. Additionally, you may evaluate how the addition of ABVC Biopharma to your portfolios can decrease your overall portfolio volatility.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Money Managers
Screen money managers from public funds and ETFs managed around the world